A clinically relevant CTLA4-Ig-based regimen induces chimerism and tolerance to heart grafts

Annals of Thoracic Surgery

Volumn 72, Issue 4, 2001, Pages 1306-1310

  Li, Sen ^b   Thanikachalam, Mohan ^b   Pang, Manhui ^b   Kawaharada, Nobuyoshi ^b   Aitouche, Abdelouahab ^b   Pham, Si M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; LYMPHOCYTE ANTIBODY; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; DRUG MECHANISM; GRAFT REJECTION; HEART TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SKIN GRAFT; WHOLE BODY RADIATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; ANTILYMPHOCYTE SERUM; BONE MARROW TRANSPLANTATION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; IMMUNOCONJUGATES; RATS; RATS, INBRED ACI; RATS, INBRED WF; SKIN TRANSPLANTATION; TRANSPLANTATION CHIMERA; TRANSPLANTATION TOLERANCE;

EID: 0034779224     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)03066-1     Document Type: Article

References (20)

1. Mixed allogeneic chimerism as an approach to transplantation tolerance
2. T cell depletion for graft-versus-host disease prophylaxis. A perspective on engraftment in mice and humans
3. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts
4. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts
5. Establishment of stable multilineage hematopoietic chimerism and donor-specific tolerance without irradiation
6. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance
7. Simultaneous donor bone marrow and cardiac transplantation: Can tolerance be induced with the development of chimerism?
8. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A
9. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation
10. Prevention of graft failure by cyclosporine in rats receiving lymphocyte-depleted MHC-mismatched bone marrow
11. Combined host-conditioning with CTLA4-Ig, tacrolimus, anti-lymphocyte serum and low dose radiation leads to stable mixed hematopoietic chimerism in rats
12. Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy
13. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes
14. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
15. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates
16. CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression
17. Mixed allogeneic chimerism in the rat: Donor-specific transplantation tolerance and prevention of chronic rejection for primarily vascularized cardiac allografts
18. Phenotypic characterization of a novel bone-marrow derived cell that facilitates engraftment of allogeneic bone marrow stem cells
19. Characterization of a newly discovered T-cell receptor beta-chain heterodimer expressed on a CD8+ bone marrow subpopulation that promotes allogeneic stem cell engraftment
20. T-cell depletion of allogeneic bone marrow using anti-alphabeta TCR monoclonal antibody: Prevention of graft-versus-host disease without affecting engraftment potential in rats